A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions.

MLA

Wu, P., et al. “A New Antihistamine Levocetirizine Inhibits Eosinophil Adhesion to Vascular Cell Adhesion Molecule-1 under Flow Conditions.” Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, vol. 35, no. 8, Aug. 2005, pp. 1073–79. EBSCOhost, https://doi.org/10.1111/j.1365-2222.2005.02290.x.

APA

Wu, P., Mitchell, S., & Walsh, G. M. (2005). A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 35(8), 1073–1079. https://doi.org/10.1111/j.1365-2222.2005.02290.x

Chicago

Wu, P, S Mitchell, and G M Walsh. 2005. “A New Antihistamine Levocetirizine Inhibits Eosinophil Adhesion to Vascular Cell Adhesion Molecule-1 under Flow Conditions.” Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 35 (8): 1073–79. doi:10.1111/j.1365-2222.2005.02290.x.